A Review on Various Analytical and Biological Methods for the Determination of Tepotinib

Gangu Sreelatha; N. Sai Lokesh; K. Sanihitha

A Review on Various Analytical and Biological Methods for the Determination of Tepotinib

Authors: Gangu Sreelatha, N. Sai Lokesh, K. Sanihitha

Unique Paper ID: 161663
Volume: 10
Issue: 5
PageNo: 312-317

Keywords: Tepotinib Tyrosine MET Fibroblast Urothelial Carcinoma Sotorasib Darolutamide.

Abstract:
Tepotinib is a MET tyrosine kinase inhibitor used to treat solid tumors that overexpress MET. There were several phases of clinical trials, and only a few analytical methods for Tepotinib were established using RP-HPLC technology. Chromatography makes use of the stationary phase. Ascentis 150 mm x 4.6 mm x 2.7 m, mobile phase Acetonitrile: 0.1% OPA in a 50:50 mixture, pumped at 1 ml/min, detection wavelength of 310 nm, column temperature of 30oC, and mobile phase as the diluent. Tepotinib (TPT), a fibroblast growth factor receptor inhibitor and anticancer medicine, has been approved by the FDA for use in the chemotherapy of urothelial carcinoma. HSA binding may affect the pharmacokinetics and pharmacodynamics of anticancer medicines. Tepotinib (TEPO), sotorasib (SOTO), and darolutamide (DARO) were tested as novel anticancer drugs utilizing a well-established, simple, rapid, and sensitive spectrofluorimetric approach. The spectrofluorimetric approach was based on the quantitative quenching of MER fluorescence at 538 nm after it had been activated at 350 nm with the prescribed drugs. Tepotinib, a highly selective MET inhibitor, was investigated in this Phase 1b/2 study in patients from the United States and Europe with advanced hepatocellular carcinoma (AHCC) who had previously received sorafenib treatment and showed MET overexpression.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 10
Issue: 5
PageNo: 312-317

A Review on Various Analytical and Biological Methods for the Determination of Tepotinib

Available:https://ijirt.org/Article?manuscript=161663

19 Jul, 2023

A new method Development and Validation of Agomelatine by RP-HPLC in its bulk and tablet dosage form

17 Jul, 2023

A Simple UV Spectrophotometric Method Development and Validation of Melatonin in its Bulk and Pharmaceutical Dosage Forms

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry